Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cidecin (Daptomycin) vs Rocephin (Ceftriaxone) in Community-Acquired Pneumonia
NCT00540072Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2001
- Primary completion
- Feb 2002
01
Overview
A Phase 3 trial of daptomycin in community acquired pneumonia (CAP), sponsored by Merck & Co.. Started Jul 2001; status: completed.
02
Drugs
daptomycin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00540072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540072.